Literature DB >> 10976242

Vacuum-assisted large-core breast biopsy: complications and their incidence.

J T Lai1, P Burrowes, J H MacGregor.   

Abstract

OBJECTIVE: To assess both the rate and types of complications associated with vacuum-assisted large-core breast biopsy (VALCBB) at our institution.
METHODS: Three hundred and four VALCBBs performed in 297 patients between Sept. 18, 1997, and Mar. 30, 1999, were evaluated. Complications associated with VALCBB were assessed at the time of the procedure and in the post-procedure period. Adverse outcomes included pain, bleeding or bruising, and hematoma. Complications were also classified in terms of minor, significant, and major severity.
RESULTS: VALCBB yielded non-minor (i.e., significant and major) complication rates of 3.9% during the procedure and 3.6% in the post-procedure period, with only 2 complications (vasovagal-induced seizure and migraine) that required treatment.
CONCLUSION: With proper technique and patient preparation, VALCBB is a very safe procedure with a low complication rate.

Entities:  

Mesh:

Year:  2000        PMID: 10976242

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  4 in total

1.  Ultrasound-guided vacuum-assisted breast biopsy system for diagnosis and minimally invasive excision of intraductal papilloma without nipple discharge.

Authors:  Hu Wei; Fan Jiayi; Zhang Qinping; Shi Junyi; Shen Yuan; Li Li; Su Dongwei; Qing Liying
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

2.  Vacuum-Assisted Breast Biopsy System: No Innovation Without Evaluation.

Authors:  Sherif Monib; Soumitra Mukerji; Sonia Narula
Journal:  Cureus       Date:  2021-01-12

3.  Acquired arteriovenous fistula of the breast following ultrasound guided biopsy of invasive ductal carcinoma.

Authors:  Adam Gregg; Rebecca Leddy; Madelene Lewis; Abid Irshad
Journal:  J Clin Imaging Sci       Date:  2013-09-27

4.  Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.

Authors:  Meredith C Henderson; Alan B Hollingsworth; Kelly Gordon; Michael Silver; Rao Mulpuri; Elias Letsios; David E Reese
Journal:  PLoS One       Date:  2016-08-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.